Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
Lucas Moreno, Giuseppe Barone, Steven G. DuBois, Jan J. Molenaar, Matthias Fischer, Johannes H. Schulte, Angelika Eggert, Gudrun Schleiermacher, Frank Speleman, Louis Chesler, Birgit Geoerger, Michael D. Hogarty, Meredith S. Irwin, Nick Bird, Guy B. Blanchard, Sean Buckland, Hubert Caron, Susan R. Davis, Bram De Wilde, Hedwig E. Deubzer, M. Emmy M. Dolman, Martin Eilers, Rani E. George, Sally L. George, Štěrba Jaroslav, John M. Maris, Lynley V. Marshall, Melinda S. Merchant, Peter G. Mortimer, Cormac Owens, Anna Philpott, Evon Poon, Jerry W. Shay, Roberto Tonelli, Dominique Valteau‐Couanet, Gilles Vassal, Julie R. Park, Andrew D.J. Pearson
Topics & Concepts
NeuroblastomaMedicineClinical trialDrug developmentDrugATRXOncologyPharmacologyInternal medicineBiologyMutationGeneticsCell cultureGeneNeuroblastoma Research and TreatmentsCancer therapeutics and mechanismsProtein Degradation and Inhibitors